Radware Report Ranks Top 15 Most Active Political and Religious Hacktivists
Provides a deep dive into 60 days of DDoS attacks led by the world’s most…
Month: April 2023
Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients
Data at EBMT show primary endpoint met – estimated* 92.2% of complement-inhibitor-naïve patients with paroxysmal…
Nozomi Networks Earns Publisher’s Choice for OT and IoT Endpoint Security in 2023 Global InfoSec Awards
SAN FRANCISCO, April 26, 2023 (GLOBE NEWSWIRE) — Nozomi Networks, the leader in OT and…
Orbital Therapeutics Secures $270 Million in Series A Financing to Unleash Full Potential of RNA Medicines
Financing Supports Advancement of an Industry-leading, Comprehensive Platform of RNA Technologies and a First-in-Class Portfolio…
Alimama Top Brand Project Launches “Earthshaking Ceramics” Community Outreach Program
Hangzhou, China–(Newsfile Corp. – April 26, 2023) – Alimama Top Brand Project is pleased to…
Summary of 2023 Honda Business Briefing
TOKYO, Apr 26, 2023 – (JCN Newswire) – Honda Motor Co., Ltd. today held a…
World CX Summit – India to Showcase the Impact of Customer Centricity on Business Growth
New Delhi, India, Apr 26, 2023 – (ACN Newswire) – The 10th Global Edition of…
Hilton Reports First Quarter Results; Raises Full Year Outlook
MCLEAN, Va.–(BUSINESS WIRE)–Hilton Worldwide Holdings Inc. (“Hilton” or the “Company”) (NYSE: HLT) today reported its…
Summer Announces $6M in New Funding to Accelerate Growth of its Student Debt and Education Assistance Offering
Summer has surpassed $1 billion in total student loan savings for borrowers NEW YORK–(BUSINESS WIRE)–Summer,…
Senhasegura Named Winner of Global InfoSec Award for Hot Privileged Access Management (PAM) During RSA Conference 2023
Senhasegura’s 360o Privileged Platform offers a powerful yet easy-to-use solution to secure a company’s increasingly…
Vertiv Reports First Quarter Operating Profit of $130 Million and Adjusted Operating Profit(1) of $176 Million, Up $163 Million; Operating Cash Flow of $42 Million, Up $174 Million; Full Year 2023 Profit Guidance Raised
Strong first quarter net sales growth of 32% and organic net sales growth(1) of 35%,…
Mainz Biomed Announces Partnership with the Instituto de Microecologia to Expand ColoAlert® Commercialization in Spain and Portugal
The Instituto de Microecologia to market at-home detection test for colorectal cancer to physicians and…
Transfer of Nicox’s shares to Euronext Growth Paris effective on April 28, 2023
Press Release Transfer of Nicox’s shares to Euronext Growth Paris effective on April 28, 2023…
Press Release: Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Provention Bio, Inc.
Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Provention Bio, Inc. Paris, France – April…
Mendus announces two upcoming presentations at the 2023 CIMT Annual Meeting
UPDATED CLINICAL DATA FROM ADVANCE II TRIAL TO BE SHARED IN AN ORAL PRESENTATION AND…
C4X Discovery Holdings plc: Half-year results for the six months ended 31 January 2023
This announcement contains inside information C4X Discovery Holdings plc(“C4XD”, “C4X Discovery” or the “Company”) Half-year…
Novozymes delivers stronger than expected Q1 results
After the first quarter of 2023, Novozymes delivers stronger results than expected with 5% organic…
Interim report for Q1 2023
Please read the full report in PDF Attachment 2023_52_Q12023_CompanyAnnouncement
Virbac : Public release of Virbac Annual Report at 31 December 2022 (ESEF format)
Public release of Virbac Annual Report at 31 December 2022 (ESEF format). The Group released…
New Data on Two Nicox’s Assets, NCX 470 and NCX 1728, Presented at ARVO 2023
Press Release New Data on Two Nicox’s Assets, NCX 470 and NCX 1728, Presented at…